Phospho-IGF2R (Ser2409) Antibody

What is the Phospho-IGF2R (Ser2409) antibody and what does it specifically detect?

The Phospho-IGF2R (Ser2409) antibody is a polyclonal antibody that specifically detects endogenous levels of IGF2R only when phosphorylated at serine 2409. This antibody recognizes the phosphorylated form of the cation-independent mannose 6-phosphate receptor (CI-MPR), which is also known as insulin-like growth factor 2 receptor (IGF2R). The antibody is typically raised in rabbits against a synthetic phosphopeptide derived from human IGF2R around the phosphorylation site of Ser2409 . The immunogen typically consists of a peptide sequence spanning positions 2381-2430 containing the phosphorylated serine residue .

What are the validated applications for Phospho-IGF2R (Ser2409) antibody?

According to validation data, the Phospho-IGF2R (Ser2409) antibody has been verified for multiple experimental applications:

The antibody has been specifically tested in these applications, with validation images showing specific detection of phosphorylated IGF2R in Western blots from COS7 cells treated with UV radiation, as well as in paraffin-embedded human brain tissue sections .

What species reactivity has been confirmed for this antibody?

Based on experimental validation, the Phospho-IGF2R (Ser2409) antibody exhibits cross-reactivity with:

• Human IGF2R

• Mouse IGF2R

• Monkey IGF2R

This multi-species reactivity makes it valuable for comparative studies across different model organisms . Researchers should note that cross-reactivity testing has confirmed that this antibody does not exhibit non-specific binding to other proteins.

What are the optimal storage conditions for maintaining antibody activity?

For long-term storage of Phospho-IGF2R (Ser2409) antibody, the following conditions should be maintained:

• Store at -20°C for up to one year

• For frequent use within one month, storage at 4°C is acceptable

• Avoid repeated freeze-thaw cycles as they may compromise antibody performance

• The antibody is typically supplied in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide to maintain stability

To empirically assess storage effects, researchers should perform time-course comparisons of antibody performance using consistent positive controls.

How should phospho-specificity be validated in experimental workflows?

To confirm that the antibody is detecting the phosphorylated form of IGF2R and not the unphosphorylated form, researchers should implement the following validation approaches:

• Blocking peptide controls: Compare staining patterns with and without pre-incubation with the phosphopeptide used as the immunogen. Specific signal should be abolished in the presence of the phosphopeptide .

• Phosphatase treatment controls: Treat a duplicate sample with lambda phosphatase before antibody incubation. The signal should disappear if it's genuinely phospho-specific.

• Stimulation/inhibition experiments: Compare samples where phosphorylation is induced (e.g., UV treatment of COS7 cells has been validated) versus uninduced controls .

Validation images demonstrating loss of signal with phosphopeptide blocking have been documented in both Western blotting and immunohistochemistry applications .

How does the phosphorylation at Ser2409 relate to IGF2R trafficking and function?

The IGF2R/CI-MPR protein plays crucial roles in two distinct but interconnected cellular cycles:

• Biosynthetic cycle: Transport of newly synthesized lysosomal enzymes from the trans-Golgi network to late endosomes or early lysosomes.

• Endocytic cycle: Transport of extracellular lysosomal enzymes from the plasma membrane via clathrin-coated vesicles to early endosomes .

Phosphorylation at Ser2409 appears to be involved in regulating these trafficking events. The entire pool of MPRs cycles between these cellular compartments every 3 hours, with steady state distribution predominantly within late endosomes, fewer in the trans-Golgi network, and approximately 10% at the cell surface . Research suggests that phosphorylation states may influence the steady-state distribution and internalization rates of the receptor.

What experimental approaches can differentiate phosphorylation at Ser2409 versus other phosphorylation sites like Ser2484?

Both Ser2409 and Ser2484 are documented phosphorylation sites on IGF2R, but they likely serve distinct regulatory functions. To differentiate their roles:

• Site-specific antibody comparison: Use both Phospho-IGF2R (Ser2409) and Phospho-IGF2R (Ser2484) antibodies in parallel experiments to compare phosphorylation patterns under various conditions.

• Mutagenesis studies: Express IGF2R constructs with S2409A and/or S2484A mutations to determine specific functional consequences.

• Kinase inhibitor profiling: Identify the specific kinases responsible for each phosphorylation site by screening inhibitors and observing differential effects on phosphorylation levels.

• Temporal analysis: Monitor phosphorylation at each site during cellular responses to determine if they occur sequentially or independently .

This comparative approach allows researchers to dissect the specific signaling pathways regulating each phosphorylation event.

What are the most common sources of false positives and false negatives when using this antibody?

When working with Phospho-IGF2R (Ser2409) antibody, researchers should be aware of these potential issues:

Potential false positives:

• Cross-reactivity with related phosphoproteins (though validation has shown high specificity)

• Detection of non-specific bands in Western blot due to sample overloading

• Autofluorescence or endogenous peroxidase activity in IHC applications

Potential false negatives:

• Rapid dephosphorylation during sample preparation (use phosphatase inhibitors)

• Epitope masking due to protein-protein interactions

• Insufficient antigen retrieval in fixed tissues

• Antibody degradation due to improper storage

To mitigate these issues, always include appropriate controls and optimize protocols for each experimental system .

How can researchers optimize antibody performance for low abundance phospho-IGF2R detection?

For detecting low levels of phosphorylated IGF2R:

• Sample enrichment: Consider using phosphoprotein enrichment techniques before immunodetection.

• Signal amplification: For IHC, implement tyramide signal amplification or polymer-based detection systems.

• Enhanced chemiluminescence: Use high-sensitivity ECL substrates for Western blot detection.

• Optimized blocking: Test different blocking agents (BSA vs. milk) as some may preserve phosphoepitopes better than others.

• Incubation conditions: Extend primary antibody incubation time (overnight at 4°C) and optimize concentration through titration experiments .

• Phosphatase inhibitors: Ensure complete phosphatase inhibition during sample preparation with freshly prepared inhibitor cocktails.

How does the antibody-based detection of phospho-IGF2R compare with alternative methods?

Several approaches exist for studying IGF2R phosphorylation, each with unique advantages and limitations:

Researchers should consider using multiple approaches for comprehensive phosphorylation analysis .

What is the significance of studying IGF2R phosphorylation in different disease contexts?

IGF2R functions as both a mannose-6-phosphate receptor for lysosomal enzyme trafficking and as a scavenger for IGF-II, potentially influencing IGF signaling pathways. The dual functionality makes its regulation through phosphorylation relevant to multiple disease contexts:

• Cancer biology: IGF2R acts as a tumor suppressor by sequestering IGF-II and preventing its mitogenic signaling. Altered phosphorylation may affect this tumor-suppressive function.

• Metabolic disorders: Through its role in IGF-II clearance, IGF2R phosphorylation may influence metabolic signaling pathways.

• Lysosomal storage diseases: As a key transporter of lysosomal enzymes, changes in IGF2R phosphorylation could affect lysosomal function.

• Neurodegenerative diseases: IGF2R is expressed in the brain, and phosphorylation-dependent trafficking may impact neuronal health and function .

Understanding the phosphorylation state at Ser2409 in these contexts could yield valuable insights into disease mechanisms and potential therapeutic targets.

How are novel antibody development techniques enhancing phospho-IGF2R research?

Recent advances in antibody technology are expanding research capabilities:

• Cross-species reactive antibodies: Novel approaches to generate human antibodies that recognize conserved regions of IGF2R across human, canine, and murine species are enabling comparative studies across model systems .

• Structure-guided mutagenesis: Using templates like trastuzumab 4D5-8 clone and applying structure-guided mutagenesis to generate synthetic libraries with specific binding properties .

• Phage display techniques: Selection methods that alternate between species-specific antigens are producing pan-reactive antibodies with high specificity and affinity .

These developments allow for more sophisticated experimental designs that translate between model organisms and human disease contexts.

What experimental techniques can determine the functional consequences of Ser2409 phosphorylation?

To establish cause-effect relationships between Ser2409 phosphorylation and IGF2R function:

• Phosphomimetic and phospho-dead mutations: Generate S2409E (phosphomimetic) and S2409A (phospho-dead) mutants to assess trafficking, binding, and signaling properties.

• Live-cell imaging: Use fluorescently tagged IGF2R combined with phospho-specific antibodies in immunofluorescence to track real-time changes in receptor localization following phosphorylation.

• Proximity labeling: Employ BioID or APEX techniques with wild-type versus mutant IGF2R to identify phosphorylation-dependent interaction partners.

• Kinase and phosphatase identification: Use targeted siRNA screens or inhibitor panels to identify enzymes regulating Ser2409 phosphorylation status.

• Quantitative receptor trafficking assays: Measure internalization rates, recycling efficiency, and degradation kinetics of wild-type versus mutant receptors to assess functional impacts .

These approaches would significantly advance understanding of how this specific phosphorylation event regulates IGF2R biology.